Colonoscopy is a cost-effective means of screening for colorectal cancer because it reduces mortality at relatively low incremental costs. Low compliance rates render colonoscopy every 10 years the most cost-effective primary screening strategy for colorectal cancer.
Topics:
colonoscopy, colorectal cancer, fecal occult blood test, flexible fiberoptic sigmoidoscopy, cost-effectiveness analysis, ...
Ann Intern Med. 2000;133(8):573-584. doi:10.7326/0003-4819-133-8-200010170-00007